Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma (HCC) consists of
a heterogeneous group of patients with a wide range of survival times, requiring further …

ABSTRACT Background/Aims: To elucidate the role of 18F-fluorodeoxyglucose positron
emission tomography/computed tomography (18F-FDG-PET/CT) imaging as an …

Objectives The aim of the study was to evaluate the role of 18 F-fluorodeoxyglucose PET
computed tomography (18 F-FDG PET CT) as an independent prognostic indicator in …

Purpose The aim of this study was to evaluate the prognostic value of 18 F-FDG PET/CT by
predicting histopathological findings in the pretransplant evaluation of patients with …

Purpose To elucidate the prognostic role of post-therapeutic 18 F-fluorodeoxyglucose (18 F-
FDG) positron emission tomography (PET), we conducted a retrospective cohort study …

Purpose This retrospective study investigated the usefulness of F-18 fluorodeoxyglucose
(FDG) positron emission tomography/computed tomography (PET/CT) after interventional …

Purpose The prognostic value of 18 F-deoxyglucose positron emission tomography (18 F-
FDG PET) on hepatocellular carcinoma (HCC) remains inconclusive. This study aims to …

Although several prognostic factors are used to predict recurrence and to select adequate
candidates for liver transplantation for hepatocellular carcinoma (HCC), these prognostic …

Purpose The purpose of this study was to investigate the predictable value of pretreatment
18 F-fluorodeoxyglucose positron emission tomography-computed tomography (18 F-FDG …

Abstract Background Fluorine 18 (18F) fluorodeoxyglucose (FDG) positron emission
tomography/computed tomography (PET/CT) has limitations in staging hepatocellular …